Are Two FDA Approvals in One Week a Positive Sign?
Don't count on it.

Biosimilar and Biomarker Approvals to Cut Costs - Research Report on Micromet, Inc. and CEL-SCI Corporation
MACAU--(Marketwire - 06/13/11) - Today, www.EquityMarketsInc.com announced its research report highlighting Micromet, Inc. (NASDAQ: MITI - News ) and CEL-SCI Corporation (AMEX: CVM - News ). Full content and research is available at www.EquityMarketsInc.com/research.php . This sector demonstrates renewed investor interest as new and lucrative ...